Ethical Guidelines for Nova Biotechnologica et Chimica
In order to ensure that works published in Nova Biotechnologica et Chimica are reliable and meet the ethical standards expected by the global scientific community, we have developed the following code of ethics to support editors, authors and peer reviewers in understanding the standards of behaviour they should follow in performing their roles in the journal publishing process.
- The editors of Nova Biotechnologica et Chimica accept and evaluate submitted manuscripts for their intellectual content regardless of race, gender, nationality, ethics origin, political philosophy, religious belief or sexual orientation of the authors.
- Editors must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
- Editors decide whether manuscripts will be accepted, rejected or need to be revised prior to acceptance. The publishing decision is based on the recommendation of the journal’s reviewers. Editors can reject manuscript at any stage of reviewing process in case the manuscript does not meet the qualitative or formal standards of the journal.
- Unpublished manuscripts or materials must not be used in an editor’s own research.
- Editorial assistance to authors is free of charge; editors can have no benefit from publication of any manuscript. Editors should pass manuscripts in which they have potential conflicts of interests to another member of the editorial board to review and consider.
- Authors declare in Letter to the Editor (or within e-mail) that paper is their own, original and unpublished work.
- Authors guarantee that the manuscript has not been copied or (self)plagiarised (in whole or in part). Manuscripts should contain sufficient details and all relevant references to allow reproducibility of the work.
- Authors guarantee that the results are presented in the manuscript clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image-based manipulation).
- All used information resources (phrases, data, images, …) must be properly cited or quoted.
- Affiliation (all authors/co-authors) and corresponding address (main author) must be clearly stated
- Adding and/or deleting authors during the revision stages should be explained in detail by authors; the complete agreement with signatures of all authors will be required by editors in this case. Changes to authorship cannot be made after acceptance of a manuscript.
- Authors should include information on sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on the welfare of animals if the research involved animals.
- Corresponding authors ensure all contributors have approved the final version of the manuscript and its submission to the journal.
- When authors recognize an error or inaccuracy in own published work, it is their obligation to notify the Editor-in-Chief and cooperate with the editor to correct or retract the paper.
- The Reviewers must treat all submitted manuscripts as confidential documents.
- The Reviewers must keep confidential all information/ideas obtained during the peer review process and must not use them for personal advantage.
- Review of manuscripts should be conducted objectively and politely but strictly and rigorously.
- Suggestions and comments of Reviewers should be supported with arguments.
Licensing & Rights
All papers published in the Nova Biotechnologica et Chimica (NBC) are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).
All articles in the NBC are supposed to be original. Authors submitting manuscript declared that submitted manuscript is original and has not previously been published in thereof and that no part of the article has been prepared from other published material.
SciCell s.r.o., as a publisher of scholarly/scientific publications, is a member of the Crossref – Digital Object Identifier (DOI) Registration Agency of the International DOI Foundation.
As a member of Crossref, the SciCell participate on publishers plagiarism prevention initiative and used service Similarity Check (Turnitin – database iThenticate), which helps editors compare of own submitted content/articles for originality/similarity to other published academic and non-academic content on the web.
Screening software is applicate by editors of the Nova Biotechnologica et Chimica (NBC), too. Plagiarism control is a part of last evaluation process of manuscripts after paper submit and before the acceptance. Results this act are important for manuscript acceptation, or not. When plagiarism from 0 to 50 % has been detected, manuscript will be sent to author for content revision. In case of plagiarism detection >50 %, the manuscript will be rejected.
Types of plagiarism:
- plagiarism in the sense of the „use another person’s ideas or work and pretend that it is your own“ (Cambridge Dictionary) or „the practice of taking someone else’s work or ideas and passing them off as one’s own“ (Oxford Dictionaries),
- self-plagiarism (re-use of significant parts of one’s own copyrighted work without citing the original source).